- Home
- ALBT vs DSS Comparison
ALBT vs DSS Comparison
Compare ALBT & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- DSS
- Stock Information
- Founded
- ALBT 2014
- DSS 1984
- Country
- ALBT United States
- DSS United States
- Employees
- ALBT N/A
- DSS N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- DSS Containers/Packaging
- Sector
- ALBT Health Care
- DSS Consumer Discretionary
- Exchange
- ALBT Nasdaq
- DSS Nasdaq
- Market Cap
- ALBT 7.9M
- DSS 7.3M
- IPO Year
- ALBT N/A
- DSS N/A
- Fundamental
- Price
- ALBT $4.90
- DSS $0.87
- Analyst Decision
- ALBT
- DSS
- Analyst Count
- ALBT 0
- DSS 0
- Target Price
- ALBT N/A
- DSS N/A
- AVG Volume (30 Days)
- ALBT 99.4K
- DSS 82.9K
- Earning Date
- ALBT 04-14-2025
- DSS 03-31-2025
- Dividend Yield
- ALBT N/A
- DSS N/A
- EPS Growth
- ALBT N/A
- DSS N/A
- EPS
- ALBT N/A
- DSS N/A
- Revenue
- ALBT N/A
- DSS $19,097,000.00
- Revenue This Year
- ALBT N/A
- DSS N/A
- Revenue Next Year
- ALBT N/A
- DSS N/A
- P/E Ratio
- ALBT N/A
- DSS N/A
- Revenue Growth
- ALBT N/A
- DSS N/A
- 52 Week Low
- ALBT $2.11
- DSS $0.77
- 52 Week High
- ALBT $21.60
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- ALBT 43.81
- DSS 43.96
- Support Level
- ALBT $5.18
- DSS $0.78
- Resistance Level
- ALBT $7.89
- DSS $1.03
- Average True Range (ATR)
- ALBT 0.64
- DSS 0.10
- MACD
- ALBT -0.20
- DSS -0.00
- Stochastic Oscillator
- ALBT 12.48
- DSS 25.97
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.